Akili Interactive Labs Inc. raised $13 million in new funding under its series C financing.
The additional funds bring the company's total equity raised in 2018 to $68 million.
Boston-based Akili Interactive Labs is a prescription digital medicine company that develops neurological and psychiatric treatments in the form of video games. The company is majority owned by PureTech Health PLC.